These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 22741778

  • 1. Selective inhibition of inducible nitric oxide synthase by derivatives of acetamidine.
    Maccallini C, Patruno A, Ammazzalorso A, De Filippis B, Fantacuzzi M, Franceschelli S, Giampietro L, Masella S, Tricca ML, Amoroso R.
    Med Chem; 2012 Nov; 8(6):991-5. PubMed ID: 22741778
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine.
    Fantacuzzi M, Maccallini C, Lannutti F, Patruno A, Masella S, Pesce M, Speranza L, Ammazzalorso A, De Filippis B, Giampietro L, Re N, Amoroso R.
    ChemMedChem; 2011 Jul 04; 6(7):1203-6. PubMed ID: 21567968
    [No Abstract] [Full Text] [Related]

  • 3. Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.
    Young RJ, Alderton W, Angell AD, Beswick PJ, Brown D, Chambers CL, Crowe MC, Dawson J, Hamlett CC, Hodgson ST, Kleanthous S, Knowles RG, Russell LJ, Stocker R, Woolven JM.
    Bioorg Med Chem Lett; 2011 May 15; 21(10):3037-40. PubMed ID: 21482467
    [Abstract] [Full Text] [Related]

  • 4. N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase.
    Maccallini C, Patruno A, Lannutti F, Ammazzalorso A, De Filippis B, Fantacuzzi M, Franceschelli S, Giampietro L, Masella S, Felaco M, Re N, Amoroso R.
    Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6495-9. PubMed ID: 20933416
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
    Arias F, Franco-Montalban F, Romero M, Carrión MD, Camacho ME.
    Bioorg Med Chem; 2021 Aug 15; 44():116294. PubMed ID: 34218000
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase.
    Maccallini C, Patruno A, Besker N, Alì JI, Ammazzalorso A, De Filippis B, Franceschelli S, Giampietro L, Pesce M, Reale M, Tricca ML, Re N, Felaco M, Amoroso R.
    J Med Chem; 2009 Mar 12; 52(5):1481-5. PubMed ID: 19203270
    [Abstract] [Full Text] [Related]

  • 7. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
    Collins JL, Shearer BG, Oplinger JA, Lee S, Garvey EP, Salter M, Duffy C, Burnette TC, Furfine ES.
    J Med Chem; 1998 Jul 16; 41(15):2858-71. PubMed ID: 9667974
    [Abstract] [Full Text] [Related]

  • 8. Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC.
    Fantacuzzi M, Maccallini C, Di Matteo M, Ammazzalorso A, Bruno I, De Filippis B, Giampietro L, Mollica A, Amoroso R.
    J Pharm Biomed Anal; 2016 Feb 20; 120():419-24. PubMed ID: 26689740
    [Abstract] [Full Text] [Related]

  • 9. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines.
    Tang W, Li H, Poulos TL, Silverman RB.
    Biochemistry; 2015 Apr 21; 54(15):2530-8. PubMed ID: 25811913
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS, Cho CH, Wang JY, Koo MW.
    Eur J Pharmacol; 2006 May 01; 536(3):301-8. PubMed ID: 16600210
    [Abstract] [Full Text] [Related]

  • 11. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    Maccallini C, Di Matteo M, Gallorini M, Montagnani M, Graziani V, Ammazzalorso A, Amoia P, De Filippis B, Di Silvestre S, Fantacuzzi M, Giampietro L, Potenza MA, Re N, Pandolfi A, Cataldi A, Amoroso R.
    Eur J Med Chem; 2018 May 25; 152():53-64. PubMed ID: 29689474
    [Abstract] [Full Text] [Related]

  • 12. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.
    Li H, Raman CS, Martásek P, Masters BS, Poulos TL.
    Biochemistry; 2001 May 08; 40(18):5399-406. PubMed ID: 11331003
    [Abstract] [Full Text] [Related]

  • 13. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
    Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H, Moilanen E.
    J Pharmacol Exp Ther; 2001 Sep 08; 298(3):1128-32. PubMed ID: 11504810
    [Abstract] [Full Text] [Related]

  • 14. Inducible nitric oxide synthase inhibitors: A comprehensive update.
    Minhas R, Bansal Y, Bansal G.
    Med Res Rev; 2020 May 08; 40(3):823-855. PubMed ID: 31502681
    [Abstract] [Full Text] [Related]

  • 15. Photo-control of nitric oxide synthase activity using a caged isoform specific inhibitor.
    Montgomery HJ, Perdicakis B, Fishlock D, Lajoie GA, Jervis E, Guy Guillemette J.
    Bioorg Med Chem; 2002 Jun 08; 10(6):1919-27. PubMed ID: 11937350
    [Abstract] [Full Text] [Related]

  • 16. A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential.
    Maccallini C, Marinelli L, Indorf P, Cacciatore I, Fantacuzzi M, Clement B, Di Stefano A, Amoroso R.
    ChemMedChem; 2020 Nov 18; 15(22):2157-2163. PubMed ID: 32783298
    [Abstract] [Full Text] [Related]

  • 17. Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.
    Claramunt RM, López C, Pérez-Medina C, Pérez-Torralba M, Elguero J, Escames G, Acuña-Castroviejo D.
    Bioorg Med Chem; 2009 Sep 01; 17(17):6180-7. PubMed ID: 19679481
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y, Nikolic D, Van Breemen RB, Silverman RB.
    J Am Chem Soc; 2005 Jan 26; 127(3):858-68. PubMed ID: 15656623
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation.
    Cárdenas A, De Alba J, Moro MA, Leza JC, Lorenzo P, Lizasoain I.
    Eur J Pharmacol; 1998 Aug 07; 354(2-3):161-5. PubMed ID: 9754916
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
    Carrión MD, Chayah M, Entrena A, López A, Gallo MA, Acuña-Castroviejo D, Camacho ME.
    Bioorg Med Chem; 2013 Jul 15; 21(14):4132-42. PubMed ID: 23735830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.